Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Scales Corporation (SCL) / FY21

PBT up 37.8% but cash conversion fell from 93.8% to 55.6%

Strong revenue and earnings growth contrasts with operating cash flow down 25.1%, leaving pre-lease FCF below the historical range.

Primary Industries / Horticulture and food

SCL revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY25 was $899.9m, versus $371.9m in HY25.

SCL EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • HY23 SCL: Outside range low ebitda margin. 9.8%; 3-period range 18.2% to 23.6%. EBITDA margin: 9.8%, below normal range; 3-period mean 20.4%, range 18.2%-23.6%.
  • FY23 SCL: Outside range low ebitda margin. 9.5%; 4-period range 11.1% to 18.9%. EBITDA margin: 9.5%, below normal range; 4-period mean 14.7%, range 11.1%-18.9%.
  • HY25 SCL: Outside range high ebitda margin. 23.6%; 3-period range 9.8% to 19.3%. EBITDA margin: 23.6%, above normal range; 3-period mean 15.8%, range 9.8%-19.3%.
  • FY25 SCL: Unprecedented high ebitda margin. 18.9%; 4-period range 9.5% to 15.1%. EBITDA margin: 18.9%, unprecedented high; 4-period mean 12.4%, range 9.5%-15.1%.
EBITDA margin: 18.9%, unprecedented high; 4-period mean 12.4%, range 9.5%-15.1%.

SCL operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY25 was $95.8m, versus -$9.2m in HY25.

SCL working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY23 SCL: Outside range high operating working-capital movement. $104.7m; 3-period range $-9.1m to $6.3m. Operating working-capital movement: NZ$104.7m, above normal range; 1/3 prior periods had builds averaging NZ$6.3m, and 2 had releases averaging NZ$-7.0m.
  • FY23 SCL: Outside range low operating working-capital movement. $-23.7m; 4-period range $7.9m to $120.1m. Operating working-capital movement: NZ$-23.7m, below normal range; 4/4 prior periods had builds averaging NZ$40.4m, and none had a working-capital release.
  • HY25 SCL: Outside range low operating working-capital movement. $-9.1m; 3-period range $-4.9m to $104.7m. Operating working-capital movement: NZ$-9.1m, below normal range; 2/3 prior periods had builds averaging NZ$55.5m, and 1 had releases averaging NZ$-4.9m.
  • FY25 SCL: Unprecedented high operating working-capital movement. $120.1m; 4-period range $-23.7m to $25.2m. Operating working-capital movement: NZ$120.1m, unprecedented high; 3/4 prior periods had builds averaging NZ$13.8m, and 1 had releases averaging NZ$-23.7m.
Operating working-capital movement: NZ$120.1m, unprecedented high; 3/4 prior periods had builds averaging NZ$13.8m, and 1 had releases averaging NZ$-23.7m.
Release date
24 February 2022
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY21 vs FY20

Revenue

$514.6m

+9.3% ↑ vs $470.7m

EBITDA

$71.6m

+26.2% ↑ vs $56.7m

Net profit after tax

$26.9m

+28.1% ↑ vs $21m

Net cash inflow from operating activities

$39.8m

-25.1% ↓ vs $53.2m

Interim dividend per share

9.5c

flat vs 9.5c

Operating profit

$52.1m

+38.6% ↑ vs $37.6m

Profit before tax

$48.5m

+37.8% ↑ vs $35.2m

Cash and cash equivalents

$35.4m

-25.3% ↓ vs $47.4m

What changed

Scales delivered headline earnings growth that did not translate to cash

Revenue rose 9.3% to NZ$514.6m and EBITDA climbed 26.2% to NZ$71.6m, lifting PBT 37.8% to NZ$48.5m and NPAT 28.1% to NZ$26.9m on a continuing-operations basis. Yet net operating cash flow fell 25.1% to NZ$39.8m, dragging OCF/EBITDA from 93.8% to 55.6% — at the floor of the four-year baseline range of 56.4%–120.5% and 32.7 percentage points below the historical mean of 88.3%.

The like-for-like comparison strips out FY20's NZ$73.0m discontinued-operation gain, so the growth shown here is the cleaner continuing read.

Mix shifted toward Food Ingredients, which grew to NZ$218.9m (42.5% of revenue, from 36.9%) with segment gross margin lifting to 16.0% from 13.3%. Horticulture revenue was broadly flat at NZ$243.4m, but segment result rose sharply to NZ$39.1m from NZ$16.0m. Logistics expanded to NZ$81.9m (15.9% share).

What matters

Cash conversion broke from the historical pattern despite stable working-capital optics

Operating working-capital movement of NZ$8.3m sits within normal range, and debtor days at 17.0 are at the lower edge of the historical range (16.5–25.8 days). So the cash gap is not driven by a stretched receivables cycle. The question is what specifically eroded conversion when the visible working-capital build looks modest.

Earnings growth is real but segment quality is shifting. Food Ingredients delivered the dominant dollar uplift and exceeded its divisional EBITDA target, while Horticulture revenue stagnated even as its segment result improved on in-market pricing. The diversification narrative is now carrying more weight than the historical apples-led story.

Balance sheet capacity remains very strong. Net debt is effectively nil at NZ$2.9m (0.04x EBITDA, from 0.12x), gross borrowings fell 29.7% to NZ$38.3m, and equity rose 3.1% to NZ$390.3m. ROE improved to 6.9% from 5.6%. There is ample capacity to absorb cash-flow volatility without strategic constraint.

Expectations

No forward financial targets are supplied in this release

The half-year shape is unusual: HY21 captured 76.1% of full-year EBITDA and 105.2% of full-year NPAT, implying second-half EBITDA of only NZ$17.1m against NZ$54.5m in HY21 and an implied 2H NPAT slightly negative. A first-half-weighted shape is normal for an apples-led horticulture business, but the magnitude of the 2H softening matters as a baseline for FY22 expectations. The release does not quantify what was 2H weakness versus shipping-related timing.

Quality of result

The earnings result is supported by genuine operating momentum, particularly in Food Ingredients where margins expanded

The durability questions sit on the cash side. Pre-lease FCF of NZ$23.3m is below the historical range of NZ$30.3m–NZ$74.9m and NZ$25.6m below the four-year mean of NZ$48.9m. This came despite capex falling 31.8% to NZ$16.5m, or 3.2% of revenue — that drop flatters FCF rather than reflecting structurally lower investment intensity, and it warrants scrutiny on sustainability.

The 49.7% NPAT payout ratio looks comfortable on earnings, but at 114.8% of pre-lease FCF the payout sits well above the three-year historical mean of 16.3%. Dividend coverage by FCF is intact, but the cushion has thinned materially. The effective tax rate of 23.9% is essentially flat against the prior 24.6%, so tax is not distorting the operating read in either direction even though it sits above the longer-run historical norm.

Unresolved

Open questions

What specifically drove OCF down 25.1% when EBITDA rose 26.2% and receivables and inventory days stayed near historical norms?
Why did capex fall to 3.2% of revenue, and is that level sustainable given the orchard and processing asset base?
How should investors interpret the implied 2H21 EBITDA of NZ$17.1m against HY21's NZ$54.5m, and what shape does management expect for FY22?
Will Food Ingredients' margin expansion to 16.0% hold if pet-food demand and input cycles normalise?
Is the dividend calibrated to NPAT or to FCF, given pre-lease FCF cover has fallen to a 57.4% payout from 45.9%?

This briefing cannot assess management's detailed outlook commentary, segment-level cash conversion, or the orchard yield and pricing variables that determine Horticulture's seasonality.

Chat

Ask about SCL FY21

Ask follow-up questions about Scales Corporation's FY21 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SCL FY21

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Scales Corporation's FY21 result.

What specifically drove OCF down 25.1% when EBITDA rose 26.2% and receivables and inventory days stayed near historical norms?Why does "Cash conversion broke from the historical pattern despite stable working-capital optics" matter?How strong was the cash and earnings quality in FY21?What should I watch next for SCL after FY21?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Annual Financial Statements - 31 December 2021

FY21 / financial report↗

Annual Results Announcement - 31 December 2021

FY21 / results announcement↗

Annual Results Media Release - 31 December 2021

FY21 / media release↗

Annual Results Presentation - 31 December 2021

FY21 / results presentation↗

Prior comparable period

2020 Annual Report

FY20 / financial report↗

Interim context

Financial Statements - 30 June 2021

HY21 / financial report↗

Interim Results Announcement - 30 June 2021

HY21 / results announcement↗

Interim Results Media Release - 30 June 2021

HY21 / media release↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 55.6% of EBITDA to operating cash flow, -38.2pp versus the prior comparable period.

→

Dividend coverage and payout pressure

Dividend payout versus pre-lease FCF is 114.8%, with NPAT payout at 49.7%.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 9.7pp.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 0.04x, -0.08x versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when SCL publishes next

Get the next Scales Corporation briefing and related NZX reporting-season updates by email.